Global Vaginal Fungi Infections Treatment Market 2021 by Company, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 237021
  • calendar_today Published On: Dec, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Vaginal Fungi Infections Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Vaginal Fungi Infections Treatment size is estimated to be USD million in 2026 from USD million in 2020, with a change % between 2020 and 2021. The global Vaginal Fungi Infections Treatment market size is expected to grow at a CAGR of % for the next five years.

Market segmentation

Vaginal Fungi Infections Treatment market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Fluconazole

Nystatin

Flucytosine

Others

Market segment by Application, can be divided into

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Market segment by players, this report covers

Pfizer Inc.

Bausch Health Companies Inc

ANI Pharmaceuticals

Hikma Pharmaceuticals Plc

Lupin Limited

Mycovia Pharmaceuticals

Glenmark Pharmaceuticals Limited

Unique Pharmaceuticals

PEPTONIC medical AB

Aurobindo Pharma Limited

Dr. Reddy's Laboratories

SCYNEXIS

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Vaginal Fungi Infections Treatment product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Vaginal Fungi Infections Treatment, with revenue, gross margin and global market share of Vaginal Fungi Infections Treatment from 2019 to 2021.

Chapter 3, the Vaginal Fungi Infections Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Vaginal Fungi Infections Treatment market forecast, by regions, type and distribution channel, with revenue, from 2021 to 2026.

Chapter 11 and 12, to describe Vaginal Fungi Infections Treatment research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Vaginal Fungi Infections Treatment

1.2 Classification of Vaginal Fungi Infections Treatment by Type

1.2.1 Overview: Global Vaginal Fungi Infections Treatment Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Vaginal Fungi Infections Treatment Revenue Market Share by Type in 2020

1.2.3 Fluconazole

1.2.4 Nystatin

1.2.5 Flucytosine

1.2.6 Others

1.3 Global Vaginal Fungi Infections Treatment Market by Distribution Channel

1.3.1 Overview: Global Vaginal Fungi Infections Treatment Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Online Pharmacies

1.4 Global Vaginal Fungi Infections Treatment Market Size & Forecast

1.5 Global Vaginal Fungi Infections Treatment Market Size and Forecast by Region

1.5.1 Global Vaginal Fungi Infections Treatment Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Vaginal Fungi Infections Treatment Market Size by Region, (2016-2021)

1.5.3 North America Vaginal Fungi Infections Treatment Market Size and Prospect (2016-2026)

1.5.4 Europe Vaginal Fungi Infections Treatment Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Vaginal Fungi Infections Treatment Market Size and Prospect (2016-2026)

1.5.6 South America Vaginal Fungi Infections Treatment Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Vaginal Fungi Infections Treatment Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Vaginal Fungi Infections Treatment Market Drivers

1.6.2 Vaginal Fungi Infections Treatment Market Restraints

1.6.3 Vaginal Fungi Infections Treatment Trends Analysis

2 Company Profiles

2.1 Pfizer Inc.

2.1.1 Pfizer Inc. Details

2.1.2 Pfizer Inc. Major Business

2.1.3 Pfizer Inc. Vaginal Fungi Infections Treatment Product and Solutions

2.1.4 Pfizer Inc. Vaginal Fungi Infections Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Pfizer Inc. Recent Developments and Future Plans

2.2 Bausch Health Companies Inc

2.2.1 Bausch Health Companies Inc Details

2.2.2 Bausch Health Companies Inc Major Business

2.2.3 Bausch Health Companies Inc Vaginal Fungi Infections Treatment Product and Solutions

2.2.4 Bausch Health Companies Inc Vaginal Fungi Infections Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Bausch Health Companies Inc Recent Developments and Future Plans

2.3 ANI Pharmaceuticals

2.3.1 ANI Pharmaceuticals Details

2.3.2 ANI Pharmaceuticals Major Business

2.3.3 ANI Pharmaceuticals Vaginal Fungi Infections Treatment Product and Solutions

2.3.4 ANI Pharmaceuticals Vaginal Fungi Infections Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 ANI Pharmaceuticals Recent Developments and Future Plans

2.4 Hikma Pharmaceuticals Plc

2.4.1 Hikma Pharmaceuticals Plc Details

2.4.2 Hikma Pharmaceuticals Plc Major Business

2.4.3 Hikma Pharmaceuticals Plc Vaginal Fungi Infections Treatment Product and Solutions

2.4.4 Hikma Pharmaceuticals Plc Vaginal Fungi Infections Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Hikma Pharmaceuticals Plc Recent Developments and Future Plans

2.5 Lupin Limited

2.5.1 Lupin Limited Details

2.5.2 Lupin Limited Major Business

2.5.3 Lupin Limited Vaginal Fungi Infections Treatment Product and Solutions

2.5.4 Lupin Limited Vaginal Fungi Infections Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Lupin Limited Recent Developments and Future Plans

2.6 Mycovia Pharmaceuticals

2.6.1 Mycovia Pharmaceuticals Details

2.6.2 Mycovia Pharmaceuticals Major Business

2.6.3 Mycovia Pharmaceuticals Vaginal Fungi Infections Treatment Product and Solutions

2.6.4 Mycovia Pharmaceuticals Vaginal Fungi Infections Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Mycovia Pharmaceuticals Recent Developments and Future Plans

2.7 Glenmark Pharmaceuticals Limited

2.7.1 Glenmark Pharmaceuticals Limited Details

2.7.2 Glenmark Pharmaceuticals Limited Major Business

2.7.3 Glenmark Pharmaceuticals Limited Vaginal Fungi Infections Treatment Product and Solutions

2.7.4 Glenmark Pharmaceuticals Limited Vaginal Fungi Infections Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Glenmark Pharmaceuticals Limited Recent Developments and Future Plans

2.8 Unique Pharmaceuticals

2.8.1 Unique Pharmaceuticals Details

2.8.2 Unique Pharmaceuticals Major Business

2.8.3 Unique Pharmaceuticals Vaginal Fungi Infections Treatment Product and Solutions

2.8.4 Unique Pharmaceuticals Vaginal Fungi Infections Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Unique Pharmaceuticals Recent Developments and Future Plans

2.9 PEPTONIC medical AB

2.9.1 PEPTONIC medical AB Details

2.9.2 PEPTONIC medical AB Major Business

2.9.3 PEPTONIC medical AB Vaginal Fungi Infections Treatment Product and Solutions

2.9.4 PEPTONIC medical AB Vaginal Fungi Infections Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 PEPTONIC medical AB Recent Developments and Future Plans

2.10 Aurobindo Pharma Limited

2.10.1 Aurobindo Pharma Limited Details

2.10.2 Aurobindo Pharma Limited Major Business

2.10.3 Aurobindo Pharma Limited Vaginal Fungi Infections Treatment Product and Solutions

2.10.4 Aurobindo Pharma Limited Vaginal Fungi Infections Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Aurobindo Pharma Limited Recent Developments and Future Plans

2.11 Dr. Reddy's Laboratories

2.11.1 Dr. Reddy's Laboratories Details

2.11.2 Dr. Reddy's Laboratories Major Business

2.11.3 Dr. Reddy's Laboratories Vaginal Fungi Infections Treatment Product and Solutions

2.11.4 Dr. Reddy's Laboratories Vaginal Fungi Infections Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Dr. Reddy's Laboratories Recent Developments and Future Plans

2.12 SCYNEXIS

2.12.1 SCYNEXIS Details

2.12.2 SCYNEXIS Major Business

2.12.3 SCYNEXIS Vaginal Fungi Infections Treatment Product and Solutions

2.12.4 SCYNEXIS Vaginal Fungi Infections Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 SCYNEXIS Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Vaginal Fungi Infections Treatment Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Vaginal Fungi Infections Treatment Players Market Share

3.2.2 Top 10 Vaginal Fungi Infections Treatment Players Market Share

3.2.3 Market Competition Trend

3.3 Vaginal Fungi Infections Treatment Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Vaginal Fungi Infections Treatment Revenue and Market Share by Type (2016-2021)

4.2 Global Vaginal Fungi Infections Treatment Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Vaginal Fungi Infections Treatment Revenue Market Share by Application (2016-2021)

5.2 Vaginal Fungi Infections Treatment Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Vaginal Fungi Infections Treatment Revenue by Type (2016-2026)

6.2 North America Vaginal Fungi Infections Treatment Revenue by Application (2016-2026)

6.3 North America Vaginal Fungi Infections Treatment Market Size by Country

6.3.1 North America Vaginal Fungi Infections Treatment Revenue by Country (2016-2026)

6.3.2 United States Vaginal Fungi Infections Treatment Market Size and Forecast (2016-2026)

6.3.3 Canada Vaginal Fungi Infections Treatment Market Size and Forecast (2016-2026)

6.3.4 Mexico Vaginal Fungi Infections Treatment Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Vaginal Fungi Infections Treatment Revenue by Type (2016-2026)

7.2 Europe Vaginal Fungi Infections Treatment Revenue by Application (2016-2026)

7.3 Europe Vaginal Fungi Infections Treatment Market Size by Country

7.3.1 Europe Vaginal Fungi Infections Treatment Revenue by Country (2016-2026)

7.3.2 Germany Vaginal Fungi Infections Treatment Market Size and Forecast (2016-2026)

7.3.3 France Vaginal Fungi Infections Treatment Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Vaginal Fungi Infections Treatment Market Size and Forecast (2016-2026)

7.3.5 Russia Vaginal Fungi Infections Treatment Market Size and Forecast (2016-2026)

7.3.6 Italy Vaginal Fungi Infections Treatment Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Vaginal Fungi Infections Treatment Revenue by Type (2016-2026)

8.2 Asia-Pacific Vaginal Fungi Infections Treatment Revenue by Application (2016-2026)

8.3 Asia-Pacific Vaginal Fungi Infections Treatment Market Size by Region

8.3.1 Asia-Pacific Vaginal Fungi Infections Treatment Revenue by Region (2016-2026)

8.3.2 China Vaginal Fungi Infections Treatment Market Size and Forecast (2016-2026)

8.3.3 Japan Vaginal Fungi Infections Treatment Market Size and Forecast (2016-2026)

8.3.4 South Korea Vaginal Fungi Infections Treatment Market Size and Forecast (2016-2026)

8.3.5 India Vaginal Fungi Infections Treatment Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Vaginal Fungi Infections Treatment Market Size and Forecast (2016-2026)

8.3.7 Australia Vaginal Fungi Infections Treatment Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Vaginal Fungi Infections Treatment Revenue by Type (2016-2026)

9.2 South America Vaginal Fungi Infections Treatment Revenue by Application (2016-2026)

9.3 South America Vaginal Fungi Infections Treatment Market Size by Country

9.3.1 South America Vaginal Fungi Infections Treatment Revenue by Country (2016-2026)

9.3.2 Brazil Vaginal Fungi Infections Treatment Market Size and Forecast (2016-2026)

9.3.3 Argentina Vaginal Fungi Infections Treatment Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Vaginal Fungi Infections Treatment Revenue by Type (2016-2026)

10.2 Middle East & Africa Vaginal Fungi Infections Treatment Revenue by Application (2016-2026)

10.3 Middle East & Africa Vaginal Fungi Infections Treatment Market Size by Country

10.3.1 Middle East & Africa Vaginal Fungi Infections Treatment Revenue by Country (2016-2026)

10.3.2 Turkey Vaginal Fungi Infections Treatment Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Vaginal Fungi Infections Treatment Market Size and Forecast (2016-2026)

10.3.4 UAE Vaginal Fungi Infections Treatment Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Vaginal Fungi Infections Treatment Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Vaginal Fungi Infections Treatment Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Vaginal Fungi Infections Treatment Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Vaginal Fungi Infections Treatment Revenue (USD Million) by Region (2016-2021)

Table 5. Global Vaginal Fungi Infections Treatment Revenue Market Share by Region (2021-2026)

Table 6. Pfizer Inc. Corporate Information, Head Office, and Major Competitors

Table 7. Pfizer Inc. Major Business

Table 8. Pfizer Inc. Vaginal Fungi Infections Treatment Product and Solutions

Table 9. Pfizer Inc. Vaginal Fungi Infections Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Bausch Health Companies Inc Corporate Information, Head Office, and Major Competitors

Table 11. Bausch Health Companies Inc Major Business

Table 12. Bausch Health Companies Inc Vaginal Fungi Infections Treatment Product and Solutions

Table 13. Bausch Health Companies Inc Vaginal Fungi Infections Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. ANI Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 15. ANI Pharmaceuticals Major Business

Table 16. ANI Pharmaceuticals Vaginal Fungi Infections Treatment Product and Solutions

Table 17. ANI Pharmaceuticals Vaginal Fungi Infections Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Hikma Pharmaceuticals Plc Corporate Information, Head Office, and Major Competitors

Table 19. Hikma Pharmaceuticals Plc Major Business

Table 20. Hikma Pharmaceuticals Plc Vaginal Fungi Infections Treatment Product and Solutions

Table 21. Hikma Pharmaceuticals Plc Vaginal Fungi Infections Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Lupin Limited Corporate Information, Head Office, and Major Competitors

Table 23. Lupin Limited Major Business

Table 24. Lupin Limited Vaginal Fungi Infections Treatment Product and Solutions

Table 25. Lupin Limited Vaginal Fungi Infections Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Mycovia Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 27. Mycovia Pharmaceuticals Major Business

Table 28. Mycovia Pharmaceuticals Vaginal Fungi Infections Treatment Product and Solutions

Table 29. Mycovia Pharmaceuticals Vaginal Fungi Infections Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Glenmark Pharmaceuticals Limited Corporate Information, Head Office, and Major Competitors

Table 31. Glenmark Pharmaceuticals Limited Major Business

Table 32. Glenmark Pharmaceuticals Limited Vaginal Fungi Infections Treatment Product and Solutions

Table 33. Glenmark Pharmaceuticals Limited Vaginal Fungi Infections Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Unique Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 35. Unique Pharmaceuticals Major Business

Table 36. Unique Pharmaceuticals Vaginal Fungi Infections Treatment Product and Solutions

Table 37. Unique Pharmaceuticals Vaginal Fungi Infections Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. PEPTONIC medical AB Corporate Information, Head Office, and Major Competitors

Table 39. PEPTONIC medical AB Major Business

Table 40. PEPTONIC medical AB Vaginal Fungi Infections Treatment Product and Solutions

Table 41. PEPTONIC medical AB Vaginal Fungi Infections Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Aurobindo Pharma Limited Corporate Information, Head Office, and Major Competitors

Table 43. Aurobindo Pharma Limited Major Business

Table 44. Aurobindo Pharma Limited Vaginal Fungi Infections Treatment Product and Solutions

Table 45. Aurobindo Pharma Limited Vaginal Fungi Infections Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Dr. Reddy's Laboratories Corporate Information, Head Office, and Major Competitors

Table 47. Dr. Reddy's Laboratories Major Business

Table 48. Dr. Reddy's Laboratories Vaginal Fungi Infections Treatment Product and Solutions

Table 49. Dr. Reddy's Laboratories Vaginal Fungi Infections Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. SCYNEXIS Corporate Information, Head Office, and Major Competitors

Table 51. SCYNEXIS Major Business

Table 52. SCYNEXIS Vaginal Fungi Infections Treatment Product and Solutions

Table 53. SCYNEXIS Vaginal Fungi Infections Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. Global Vaginal Fungi Infections Treatment Revenue (USD Million) by Players (2019-2021)

Table 55. Global Vaginal Fungi Infections Treatment Revenue Share by Players (2019-2021)

Table 56. Breakdown of Vaginal Fungi Infections Treatment by Company Type (Tier 1, Tier 2 and Tier 3)

Table 57. Vaginal Fungi Infections Treatment Players Head Office, Products and Services Provided

Table 58. Vaginal Fungi Infections Treatment Mergers & Acquisitions in the Past Five Years

Table 59. Vaginal Fungi Infections Treatment New Entrants and Expansion Plans

Table 60. Global Vaginal Fungi Infections Treatment Revenue (USD Million) by Type (2016-2021)

Table 61. Global Vaginal Fungi Infections Treatment Revenue Share by Type (2016-2021)

Table 62. Global Vaginal Fungi Infections Treatment Revenue Forecast by Type (2021-2026)

Table 63. Global Vaginal Fungi Infections Treatment Revenue by Application (2016-2021)

Table 64. Global Vaginal Fungi Infections Treatment Revenue Forecast by Application (2021-2026)

Table 65. North America Vaginal Fungi Infections Treatment Revenue by Type (2016-2021) & (USD Million)

Table 66. North America Vaginal Fungi Infections Treatment Revenue by Type (2021-2026) & (USD Million)

Table 67. North America Vaginal Fungi Infections Treatment Revenue by Application (2016-2021) & (USD Million)

Table 68. North America Vaginal Fungi Infections Treatment Revenue by Application (2021-2026) & (USD Million)

Table 69. North America Vaginal Fungi Infections Treatment Revenue by Country (2016-2021) & (USD Million)

Table 70. North America Vaginal Fungi Infections Treatment Revenue by Country (2021-2026) & (USD Million)

Table 71. Europe Vaginal Fungi Infections Treatment Revenue by Type (2016-2021) & (USD Million)

Table 72. Europe Vaginal Fungi Infections Treatment Revenue by Type (2021-2026) & (USD Million)

Table 73. Europe Vaginal Fungi Infections Treatment Revenue by Application (2016-2021) & (USD Million)

Table 74. Europe Vaginal Fungi Infections Treatment Revenue by Application (2021-2026) & (USD Million)

Table 75. Europe Vaginal Fungi Infections Treatment Revenue by Country (2016-2021) & (USD Million)

Table 76. Europe Vaginal Fungi Infections Treatment Revenue by Country (2021-2026) & (USD Million)

Table 77. Asia-Pacific Vaginal Fungi Infections Treatment Revenue by Type (2016-2021) & (USD Million)

Table 78. Asia-Pacific Vaginal Fungi Infections Treatment Revenue by Type (2021-2026) & (USD Million)

Table 79. Asia-Pacific Vaginal Fungi Infections Treatment Revenue by Application (2016-2021) & (USD Million)

Table 80. Asia-Pacific Vaginal Fungi Infections Treatment Revenue by Application (2021-2026) & (USD Million)

Table 81. Asia-Pacific Vaginal Fungi Infections Treatment Revenue by Region (2016-2021) & (USD Million)

Table 82. Asia-Pacific Vaginal Fungi Infections Treatment Revenue by Region (2021-2026) & (USD Million)

Table 83. South America Vaginal Fungi Infections Treatment Revenue by Type (2016-2021) & (USD Million)

Table 84. South America Vaginal Fungi Infections Treatment Revenue by Type (2021-2026) & (USD Million)

Table 85. South America Vaginal Fungi Infections Treatment Revenue by Application (2016-2021) & (USD Million)

Table 86. South America Vaginal Fungi Infections Treatment Revenue by Application (2021-2026) & (USD Million)

Table 87. South America Vaginal Fungi Infections Treatment Revenue by Country (2016-2021) & (USD Million)

Table 88. South America Vaginal Fungi Infections Treatment Revenue by Country (2021-2026) & (USD Million)

Table 89. Middle East & Africa Vaginal Fungi Infections Treatment Revenue by Type (2016-2021) & (USD Million)

Table 90. Middle East & Africa Vaginal Fungi Infections Treatment Revenue by Type (2021-2026) & (USD Million)

Table 91. Middle East & Africa Vaginal Fungi Infections Treatment Revenue by Application (2016-2021) & (USD Million)

Table 92. Middle East & Africa Vaginal Fungi Infections Treatment Revenue by Application (2021-2026) & (USD Million)

Table 93. Middle East & Africa Vaginal Fungi Infections Treatment Revenue by Country (2016-2021) & (USD Million)

Table 94. Middle East & Africa Vaginal Fungi Infections Treatment Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Vaginal Fungi Infections Treatment Picture

Figure 2. Global Vaginal Fungi Infections Treatment Revenue Market Share by Type in 2020

Figure 3. Fluconazole

Figure 4. Nystatin

Figure 5. Flucytosine

Figure 6. Others

Figure 7. Vaginal Fungi Infections Treatment Revenue Market Share by Distribution Channel in 2020

Figure 8. Hospital Pharmacies Picture

Figure 9. Retail Pharmacies Picture

Figure 10. Online Pharmacies Picture

Figure 11. Global Vaginal Fungi Infections Treatment Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 12. Global Vaginal Fungi Infections Treatment Revenue and Forecast (2016-2026) & (USD Million)

Figure 13. Global Vaginal Fungi Infections Treatment Revenue Market Share by Region (2016-2026)

Figure 14. Global Vaginal Fungi Infections Treatment Revenue Market Share by Region in 2020

Figure 15. North America Vaginal Fungi Infections Treatment Revenue (USD Million) and Growth Rate (2016-2026)

Figure 16. Europe Vaginal Fungi Infections Treatment Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. Asia-Pacific Vaginal Fungi Infections Treatment Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. South America Vaginal Fungi Infections Treatment Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. Middle East and Africa Vaginal Fungi Infections Treatment Revenue (USD Million) and Growth Rate (2016-2026)

Figure 20. Vaginal Fungi Infections Treatment Market Drivers

Figure 21. Vaginal Fungi Infections Treatment Market Restraints

Figure 22. Vaginal Fungi Infections Treatment Market Trends

Figure 23. Pfizer Inc. Recent Developments and Future Plans

Figure 24. Bausch Health Companies Inc Recent Developments and Future Plans

Figure 25. ANI Pharmaceuticals Recent Developments and Future Plans

Figure 26. Hikma Pharmaceuticals Plc Recent Developments and Future Plans

Figure 27. Lupin Limited Recent Developments and Future Plans

Figure 28. Mycovia Pharmaceuticals Recent Developments and Future Plans

Figure 29. Glenmark Pharmaceuticals Limited Recent Developments and Future Plans

Figure 30. Unique Pharmaceuticals Recent Developments and Future Plans

Figure 31. PEPTONIC medical AB Recent Developments and Future Plans

Figure 32. Aurobindo Pharma Limited Recent Developments and Future Plans

Figure 33. Dr. Reddy's Laboratories Recent Developments and Future Plans

Figure 34. SCYNEXIS Recent Developments and Future Plans

Figure 35. Global Vaginal Fungi Infections Treatment Revenue Share by Players in 2020

Figure 36. Vaginal Fungi Infections Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 37. Global Top 3 Players Vaginal Fungi Infections Treatment Revenue Market Share in 2020

Figure 38. Global Top 10 Players Vaginal Fungi Infections Treatment Revenue Market Share in 2020

Figure 39. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 40. Global Vaginal Fungi Infections Treatment Revenue Share by Type in 2020

Figure 41. Global Vaginal Fungi Infections Treatment Market Share Forecast by Type (2021-2026)

Figure 42. Global Vaginal Fungi Infections Treatment Revenue Share by Application in 2020

Figure 43. Global Vaginal Fungi Infections Treatment Market Share Forecast by Application (2021-2026)

Figure 44. North America Vaginal Fungi Infections Treatment Sales Market Share by Type (2016-2026)

Figure 45. North America Vaginal Fungi Infections Treatment Sales Market Share by Application (2016-2026)

Figure 46. North America Vaginal Fungi Infections Treatment Revenue Market Share by Country (2016-2026)

Figure 47. United States Vaginal Fungi Infections Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 48. Canada Vaginal Fungi Infections Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 49. Mexico Vaginal Fungi Infections Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 50. Europe Vaginal Fungi Infections Treatment Sales Market Share by Type (2016-2026)

Figure 51. Europe Vaginal Fungi Infections Treatment Sales Market Share by Application (2016-2026)

Figure 52. Europe Vaginal Fungi Infections Treatment Revenue Market Share by Country (2016-2026)

Figure 53. Germany Vaginal Fungi Infections Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 54. France Vaginal Fungi Infections Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 55. United Kingdom Vaginal Fungi Infections Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. Russia Vaginal Fungi Infections Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. Italy Vaginal Fungi Infections Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. Asia-Pacific Vaginal Fungi Infections Treatment Sales Market Share by Type (2016-2026)

Figure 59. Asia-Pacific Vaginal Fungi Infections Treatment Sales Market Share by Application (2016-2026)

Figure 60. Asia-Pacific Vaginal Fungi Infections Treatment Revenue Market Share by Region (2016-2026)

Figure 61. China Vaginal Fungi Infections Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. Japan Vaginal Fungi Infections Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. South Korea Vaginal Fungi Infections Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. India Vaginal Fungi Infections Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. Southeast Asia Vaginal Fungi Infections Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. Australia Vaginal Fungi Infections Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. South America Vaginal Fungi Infections Treatment Sales Market Share by Type (2016-2026)

Figure 68. South America Vaginal Fungi Infections Treatment Sales Market Share by Application (2016-2026)

Figure 69. South America Vaginal Fungi Infections Treatment Revenue Market Share by Country (2016-2026)

Figure 70. Brazil Vaginal Fungi Infections Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 71. Argentina Vaginal Fungi Infections Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. Middle East and Africa Vaginal Fungi Infections Treatment Sales Market Share by Type (2016-2026)

Figure 73. Middle East and Africa Vaginal Fungi Infections Treatment Sales Market Share by Application (2016-2026)

Figure 74. Middle East and Africa Vaginal Fungi Infections Treatment Revenue Market Share by Country (2016-2026)

Figure 75. Turkey Vaginal Fungi Infections Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 76. Saudi Arabia Vaginal Fungi Infections Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 77. UAE Vaginal Fungi Infections Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 78. Methodology

Figure 79. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz